Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mark India Biotech Private Limited is an Indian pharmaceutical company based in Mumbai that specializes in the manufacturing, marketing, and export of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various therapeutic segments, including anti-infectives, analgesics, anti-inflammatories, and cardiovascular medications. Mark India operates with a focus on providing high-quality, affordable generic medicines in multiple dosage forms such as tablets, capsules, and injectables. Adhering to WHO-GMP standards, the company serves both the domestic Indian healthcare market and several international territories. Their business model is centered on expanding access to essential medicines through a robust distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mark India.